Search research articles
Contact Us
Filters
Showing results (181-190 of 195) with videos related to
Page
of 20
Sort By:
Journal of Translational Medicine
|
August 22, 2025
In silico prediction of optimal multifactorial intervention in chronic kidney disease
Agnieszka Latosinska, Ioanna K Mina, Thi Minh Nghia Nguyen, et al.
Eclinicalmedicine
|
May 10, 2021
A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients
Ralph Wendt, Lutgarde Thijs, Sven Kalbitz, et al.
Journal of the American Society of Nephrology : JASN
|
March 13, 2015
CC Chemokine Ligand 18 in ANCA-Associated Crescentic GN
Silke R Brix, Gesa Stege, Erik Disteldorf, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 19, 2012
The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study
Felix Rosenow, Carmen Schade-Brittinger, Nicole Burchardi, et al.
Der Internist
|
August 25, 2017
[Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017]
M Koziolek, J Beige, M Wallbach, et al.
European Journal of Endocrinology
|
June 9, 2020
Pro-neurotensin depends on renal function and is related to all-cause mortality in chronic kidney disease
Anke Tönjes, Annett Hoffmann, Susan Kralisch, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 22, 2018
Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes
N Tofte, M Lindhardt, K Adamova, et al.
Seminars in Dialysis
|
August 28, 2009
The role of EUTox in uremic toxin research
Raymond Vanholder, Omar Abou-Deif, Angel Argiles, et al.
Journal of the American Society of Nephrology : JASN
|
January 16, 2015
Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides
Joost P Schanstra, Petra Zürbig, Alaa Alkhalaf, et al.
The Lancet. Diabetes & Endocrinology
|
March 6, 2020
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial
Nete Tofte, Morten Lindhardt, Katarina Adamova, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 195) with videos related to
Sort By:
Page
of 20
Journal of Translational Medicine
|
August 22, 2025
In silico prediction of optimal multifactorial intervention in chronic kidney disease
Agnieszka Latosinska, Ioanna K Mina, Thi Minh Nghia Nguyen, et al.
Eclinicalmedicine
|
May 10, 2021
A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients
Ralph Wendt, Lutgarde Thijs, Sven Kalbitz, et al.
Journal of the American Society of Nephrology : JASN
|
March 13, 2015
CC Chemokine Ligand 18 in ANCA-Associated Crescentic GN
Silke R Brix, Gesa Stege, Erik Disteldorf, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 19, 2012
The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study
Felix Rosenow, Carmen Schade-Brittinger, Nicole Burchardi, et al.
Der Internist
|
August 25, 2017
[Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017]
M Koziolek, J Beige, M Wallbach, et al.
European Journal of Endocrinology
|
June 9, 2020
Pro-neurotensin depends on renal function and is related to all-cause mortality in chronic kidney disease
Anke Tönjes, Annett Hoffmann, Susan Kralisch, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 22, 2018
Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes
N Tofte, M Lindhardt, K Adamova, et al.
Seminars in Dialysis
|
August 28, 2009
The role of EUTox in uremic toxin research
Raymond Vanholder, Omar Abou-Deif, Angel Argiles, et al.
Journal of the American Society of Nephrology : JASN
|
January 16, 2015
Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides
Joost P Schanstra, Petra Zürbig, Alaa Alkhalaf, et al.
The Lancet. Diabetes & Endocrinology
|
March 6, 2020
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial
Nete Tofte, Morten Lindhardt, Katarina Adamova, et al.
Page
of 20